Literature DB >> 3277636

Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification?

R Lotan1, G L Nicolson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3277636     DOI： 10.1016/0006-2952(88)90711-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  Antimetabolite-induced increases in the invasive capacity of murine leukaemia L1210 cells.

Authors:  T W De Graaf; G J Peters; W van Dijk
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

2.  Effects of RA 233 treatment on the adhesive, invasive and metastatic properties of 13762NF rat mammary tumor cells.

Authors:  R B Lichtner; L J Erkell; V Schirrmacher; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

3.  Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.

Authors:  N Laudonio; G Zupi; E Erba; C Leonetti; M D'Incalci
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.